volume 21 issue 3 pages 278-289

Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation

Sofia Mariasina 2, 3
Vladimir A. Pikalov 4, 5
Siva G. Somasundaram 7, 8
Cecil E. Kirkland 7, 8
Gjumrakch Aliev 9, 10
7
 
Department of Biological Sciences, Salem University, Salem, WV 26426, USA
8
 
Department of Biological Sciences, Salem University, Salem, WV 26426, USA
9
 
I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Sechenov University, 8/2 Trubetskaya Str., Moscow 119991, Russia | Research Institute of Human Morphology,3 Tsyurupy Street, Moscow 117418, Russian Federation | Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka 142432, Russia | GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX 78229, USA
10
 
I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Sechenov University, 8/2 Trubetskaya Str., Moscow 119991, Russia | Research Institute of Human Morphology,3 Tsyurupy Street, Moscow 117418, Russian Federation | Institute of Physiologically Active Compounds, Russian Academy of Sciences, Chernogolovka 142432, Russia | GALLY International Research Institute, 7733 Louis Pasteur Drive, #330, San Antonio, TX 78229, USA
Publication typeJournal Article
Publication date2022-03-01
scimago Q2
wos Q2
SJR0.710
CiteScore5.5
Impact factor3.0
ISSN18715273, 19963181
Pharmacology
General Neuroscience
Abstract
Background:

Ionizing Radiation (IR) is one of the major limiting factors for human deep-space missions. Preventing IR-induced cognitive alterations in astronauts is a critical success factor. It has been shown that cognitive alterations in rodents can be inferred by alterations of a psycho- emotional balance, primarily an anxiogenic effect of IR. In our recent work, we hypothesized that the neurokinin-1 (NK1) receptor might be instrumental for such alterations.

Objective:

The NK1 receptor antagonist rolapitant and the classic anxiolytic diazepam (as a comparison drug) were selected to test this hypothesis on Wistar rats.

Method:

Pharmacological substances were administered through intragastric probes. We used a battery of tests for a comprehensive ethological analysis. High-performance liquid chromatography was applied to quantify monoamines content. An analysis of mRNA expression was performed by real-time PCR. Protein content was studied by the Western blotting technique.

Results:

Our salient finding includes no substantial changes in anxiety, locomotor activity and cognitive abilities of treated rats under irradiation. No differences were found in the content of monoamines. We discovered a synchronous effect on mRNA expression and protein content of 5- HT2a and 5-HT4 receptors in the prefrontal cortex, as well as decreased content of serotonin transporter and increased content of tryptophan hydroxylase in the hypothalamus of irradiated rats. Rolapitant affected the protein amount of a number of serotonin receptors in the amygdala of irradiated rats.

Conclusion :

Rolapitant may be the first atypical radioprotector, providing symptomatic treatment of CNS functional disorders in astronauts caused by IR.

Found 
Found 

Top-30

Journals

1
Biology
1 publication, 10%
Life
1 publication, 10%
FEBS Journal
1 publication, 10%
Toxics
1 publication, 10%
Doklady Biological Sciences
1 publication, 10%
Radiation
1 publication, 10%
International Journal of Molecular Sciences
1 publication, 10%
Доклады Российской академии наук Науки о жизни
1 publication, 10%
Molecular Neurobiology
1 publication, 10%
International Journal of Radiation Biology
1 publication, 10%
1

Publishers

1
2
3
4
5
MDPI
5 publications, 50%
Wiley
1 publication, 10%
Pleiades Publishing
1 publication, 10%
The Russian Academy of Sciences
1 publication, 10%
Springer Nature
1 publication, 10%
Taylor & Francis
1 publication, 10%
1
2
3
4
5
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
10
Share
Cite this
GOST |
Cite this
GOST Copy
Kokhan V. S. et al. Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation // CNS and Neurological Disorders - Drug Targets. 2022. Vol. 21. No. 3. pp. 278-289.
GOST all authors (up to 50) Copy
Kokhan V. S., Mariasina S., Pikalov V. A., Абаимов Д. А., Somasundaram S. G., Kirkland C. E., Aliev G. Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation // CNS and Neurological Disorders - Drug Targets. 2022. Vol. 21. No. 3. pp. 278-289.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2174/1871527320666210122092330
UR - https://www.eurekaselect.com/190584/article
TI - Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation
T2 - CNS and Neurological Disorders - Drug Targets
AU - Kokhan, Viktor S.
AU - Mariasina, Sofia
AU - Pikalov, Vladimir A.
AU - Абаимов, Д. А.
AU - Somasundaram, Siva G.
AU - Kirkland, Cecil E.
AU - Aliev, Gjumrakch
PY - 2022
DA - 2022/03/01
PB - Bentham Science Publishers Ltd.
SP - 278-289
IS - 3
VL - 21
PMID - 33480350
SN - 1871-5273
SN - 1996-3181
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2022_Kokhan,
author = {Viktor S. Kokhan and Sofia Mariasina and Vladimir A. Pikalov and Д. А. Абаимов and Siva G. Somasundaram and Cecil E. Kirkland and Gjumrakch Aliev},
title = {Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation},
journal = {CNS and Neurological Disorders - Drug Targets},
year = {2022},
volume = {21},
publisher = {Bentham Science Publishers Ltd.},
month = {mar},
url = {https://www.eurekaselect.com/190584/article},
number = {3},
pages = {278--289},
doi = {10.2174/1871527320666210122092330}
}
MLA
Cite this
MLA Copy
Kokhan, Viktor S., et al. “Neurokinin-1 Receptor Antagonist Reverses Functional CNS Alteration Caused by Combined γ-rays and Carbon Nuclei Irradiation.” CNS and Neurological Disorders - Drug Targets, vol. 21, no. 3, Mar. 2022, pp. 278-289. https://www.eurekaselect.com/190584/article.